Value Bridge — BELLEVUE MEDICAL CENTER
Current $13M → Target $15M (+$2.5M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$12.6M
Current EBITDA
$15.1M
Target EBITDA
+$2.5M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$0.6M
Payer Mix Optimization
$1.4M
Cost to Collect Reduction
$0.5M
Clean Claim Improvement
$0.3M
Volume & Rate Growth
$2.3M
What This Means
The 7-lever model projects a 20% EBITDA uplift from $13M to $15M. The highest-impact lever is Volume & Rate Growth at $0.9M probability-weighted.
IC talking point: "We see $2M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $27M in equity value creation."